Recommendations and Treatment Outcomes for Patellofemoral Articular Cartilage Defects With Autologous Chondrocyte Implantation

Abstract

Background: Reported results of autologous chondrocyte implantation for chondral lesions in the patellofemoral joint have been encouraging when combined with realignment procedures.

Purpose: The objective of this study was to examine the clinical results of a patient cohort undergoing autologous chondrocyte implantation of the patellofemoral joint and elucidate characteristics associated with successful implantation.

Study Design: Case series; Level of evidence, 4.

Methods: The cohort included 62 patients who underwent autologous chondrocyte implantation of the PF joint. The mean defect size was 4.2 cm2 (61.6). The average age was 31.8 years (range, 15.8-49.4), and the average follow-up was 4 years (range, 2-7). Outcomes were assessed via clinical assessment and established outcome scales, including the Lysholm, International Knee Documentation Committee, Knee Injury and Osteoarthritis Outcome Scale (KOOS; includes the 5 categories of Pain, Symptoms, Activities of Daily Living, Sport, and Quality of Life), Tegner, Cincinnati, and Short Form-12.

Results: Mean improvement in the preoperative to postoperative scores was significant for the Lysholm (37-63, P<.001), International Knee Documentation Committee (31-57, P<.001), KOOS Pain (48-71, P<.001), KOOS Symptoms (51-70, P <.001), KOOS Activities of Daily Living (60-80, P <.001), KOOS Sport (25-42, P <.001), KOOS Quality of Life (24-49, P <.001), Short Form-12 Physical (38-41, P<.05), Cincinnati (43-63, P <.005), and Tegner (4-6, P <.05), but not for the Short Form-12 Mental. There was no statistical difference between outcomes in patients with a history of a previous failed cartilage procedure compared with those patients without a prior cartilage procedure (P > 05). Patients undergoing anteromedialization tended toward better outcomes than those without realignment. Forty-four percent of patients needed a subsequent procedure. There were 4 clinical failures (7.7%), which were defined as progression to arthroplasty or conversion to osteochondral allograft transplantation.

Conclusion: Autologous chondrocyte implantation is a viable treatment option for chondral defects of the patellofemoral joint. Combined autologous chondrocyte implantation with anteromedialization improves outcomes more than autologous chondrocyte implantation alone. Patients with failed prior cartilage procedures can also expect sustained and clinically meaningful improvement.

Keywords

autologous chondrocyte implantation (ACI)chondral lesions patellofemoral chondrocytes

Get full access to this article

View all access options for this article.

References

Beck PR

Thomas AL

Farr J

Lewis PB

Cole BJ

. Trochlear contact pressures after anteromedialization of the tibial tubercle.Am J Sports Med.2005;33(11):1710–1715.

Brittberg M

. Autologous chondrocyte implantation: technique and long-term follow-up.Injury.2008;39(Suppl 1):S40–S49.

Brittberg M

Lindahl A

Nilsson A

Ohlsson C

Isaksson O

Peterson L

. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.N Engl J Med.1994;331(14):889–895.

Curl WW

Krome J

Gordon ES

Rushing J

Smith BP

Poehling GG

. Cartilage injuries: a review of 31,516 knee arthroscopies.Arthroscopy.1997;13(4):456–460.

Farr J

. Autologous chondrocyte implantation improves patellofemoral cartilagetreatment outcomes. ClinOrthop Relat Res.2007;463:187–194.

Farr J

Schepsis A

Cole B

Fulkerson J

Lewis P

. Anteromedialization: review and technique.J Knee Surg.2007;20(2):120–128.

Frisbie DD

Trotter GW

Powers BE

, et al. Arthroscopic subchondral bone plate microfracture technique augments healing of large chondral defects in the radial carpal bone and medial femoral con-dyle of horses.Vet Surg.1999;28(4):242–255.

Fulkerson JP

. Anteromedialization of the tibial tuberosity for patello-femoral malalignment.Clin Orthop Relat Res.1983;177:176–181.

Fulkerson JP

. The etiology of patellofemoral pain in young, active patients: a prospective study.Clin Orthop Relat Res.1983;179: 129–133.

10.

Fulkerson JP

Shea KP

. Disorders of patellofemoral alignment.J Bone Joint Surg Am.1990;72(9):1424–1429.

11.

Gobbi A

Kon E

Berruto M

Francisco R

Filardo G

Marcacci M

. Patel-lofemoral full-thickness chondral defects treated with Hyalograft-C: a clinical, arthroscopic, and histologic review.Am J Sports Med.2006; 34(11):1763–1773.

12.

Gomoll AH

Minas T

Farr J

Cole BJ

. Treatment of chondral defects in the patellofemoral joint.J Knee Surg.2006;19(4):285–295.

13.

Hambly K

Bobic V

Wondrasch B

Van Assche D

Marlovits S

. Auto-logous chondrocyte implantation postoperative care and rehabilitation: science and practice.Am J Sports Med.2006;34(6):1020–1038.

14.

Hambly K

Griva K

. IKDC or KOOS? Which measures symptoms and disabilities most important to postoperative articular cartilage repair patients?Am J Sports Med.2008;36(9):1695–1704.

15.

Henderson IJ

Lavigne P

. Periosteal autologous chondrocyte implantation for patellar chondral defect in patients with normal and abnormal patellar tracking.Knee.2006;13(4):274–279.

16.

Kocher MS

Steadman JR

Briggs KK

Sterett WI

Hawkins RJ

. Reliability, validity, and responsiveness of the Lysholm knee scale for various chondral disorders of the knee.J Bone Joint Surg Am.2004;86(6):1139–1145.

17.

Mandelbaum B

Browne JE

Fu F

Micheli LJ

Moseley JB

Erggelet C

Anderson AF

. Treatment outcomes of autologous chondrocyte implantation for full-thickness articular cartilage defects of the troch-lea.Am J Sports Med.2007;35(6):915–921.

18.

Minas T

Bryant T

. The role of autologous chondrocyte implantation in the patellofemoral joint.Clin Orthop Relat Res.2005;436:30–39.

19.

Minas T

Gomoll AH

Rosenberger R

Royce RO

Bryant T

. Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques.Am J Sports Med.2009;37(5):902–908.

20.

Peterson L

. Articular cartilage injuries treated with autologous chon-drocyte transplantation in the human knee.Acta Orthop Belg.1996; 62(Suppl 1):196–200.

21.

Peterson L

Brittberg M

Kiviranta I

Akerlund EL

Lindahl A

. Autolo-gous chondrocyte transplantation: biomechanics and long-term durability.Am J Sports Med.2002;30(1):2–12.

22.

Pidoriano AJ

Weinstein RN

Buuck DA

Fulkerson JP

. Correlation of patellar articular lesions with results from anteromedial tibial tubercle transfer.Am J Sports Med.1997;25(4):533–537.

23.

Resnick B

Parker R

. Simplified scoring and psychometrics of the revised 12-item Short-Form Health Survey.Outcomes Manag Nurs Pract.2001;5(4):161–166.

24.

Roos EM

Roos HP

Ekdahl C

Lohmander LS

. Knee injury and Oste-oarthritis Outcome Score (KOOS): validation of a Swedish version.Scand J Med Sci Sports.1998;8(6):439–448.

25.

Scopp JM

Mandelbaum BR

. Cartilage restoration: overview of treatment options.J Knee Surg.2004;17(4):229–233.

26.

Widuchowski W

Lukasik P

Kwiatkowski G

, et al. Isolated full thickness chondral injuries. Prevalence and outcome of treatment: a retrospective study of 5233 knee arthroscopies.Acta Chir Orthop Traumatol Cech.2008;75(5):382–386.

27.

Zaslav K

Cole B

Brewster R

, et al. A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial.Am J Sports Med.2009;37(1):42–55.